1537P - Nutritional status of hospitalized cancer patients

Date 28 September 2014
Event ESMO 2014
Session Poster Display session
Topics Supportive Measures
Presenter Ali Alkan
Citation Annals of Oncology (2014) 25 (suppl_4): iv517-iv541. 10.1093/annonc/mdu356
Authors A. Alkan, D. Mizrak, G. Utkan
  • Medical Oncology, Ankara University School of Medicine, 06590 - Ankara/TR



In oncology practice, nutrition and also metabolic activity are essential .To support the nutritional status and prevent malignant cachexia, it's important to evaluate the patients and plan the maneuvers at the start of the therapy. Here we evaluated the nutritional status of patients hospitalized in oncology clinic and factors affecting the nutrition.


Patients hospitalized in oncology clinic for therapy were evaluated for food intake and nutritional status through structured interviews. The nutritional status was reported by direct observation of the total diet consumed. The clinical properties, medical therapies, elements of nutritional support were noted.


Four hundred twenty three patients, 16-82 year old (median:52),were evaluated. Female predominant group (60.9%) was mostly followed with a diagnosis of lung cancer (%31.4). Nearly half of the patients (43%) reported a better appetite at home than in hospital. One third of the patients were supporting their diet by their own effort. Most common reported reason for decreased oral intake was loss of appetite (80.4%). Total consumption of the diet provided by hospital was in only 60% of the patients. 10.6% of patients needed enteral nutrition, whereas 9.9% was followed with parenteral nutritional support. Food intake of patients with gastrointestinal malignancies were worse than others (p < 0.001). Emesis and diarrhea were important reasons for loss of diet, causing total consumption of meals in only half of the patients. Fever was an important predictor of decreased nutrition. Megestrol acetate usage in 31 patients (7.3%) provided better consumption in breakfast, lunch and dinner (p < 0.001). Chemotherapy during follow up was an important predictor for loss of consumption (p < 0.001). Steroid medication for any reason (27.2% of patients) provided a better consumption status.


In oncology practice, all patients in all stages of clinical setting must be evaluated for nutritional status and the risk groups must be supported with specific maneuvers. Gastrointestinal malignancies, especially with symptoms of emesis and diarrhea must be evaluated cautiously. Because of the effect of hospitalization on nutritional status, all unnecessary inpatient follow-ups must be avoided. Megestrol acetat in selected patients may provide better nutritional support.


All authors have declared no conflicts of interest.